Delamanid or pretomanid? A Solomonic judgement!

Given the low treatment success rates of drug-resistant tuberculosis (TB), novel TB drugs are urgently needed. The landscape of TB treatment has changed considerably over the last decade with the approval of three new compounds: bedaquiline, delamanid and pretomanid. Of these, delamanid and pretoman...

Descripción completa

Detalles Bibliográficos
Autores principales: Mudde, Saskia E., Upton, Anna M., Lenaerts, Anne, Bax, Hannelore I., De Steenwinkel, Jurriaan E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969540/
https://www.ncbi.nlm.nih.gov/pubmed/35089314
http://dx.doi.org/10.1093/jac/dkab505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969540/
https://www.ncbi.nlm.nih.gov/pubmed/35089314
http://dx.doi.org/10.1093/jac/dkab505

Ejemplares similares